학술논문

A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 1 February 2023, 29(4):711-722)
Subject
Language
English
ISSN
15573265
10780432